type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women aged over 20 years and and under 75 2) Patients from 0 to 10 years after being diagnosed with type 2 diabetes 3) Patients with HbA1c >= 6.6% with diet only during the last 12 months 4) Patients with oral diabetes drug HbA1c >= 6.2% 5) Patients with BMI> 25 kg/m2 and <45 kg/m2 6) Patients for whom consent is documented for participation in this study
Exclusion criteria
Exclusion criteria: 1) Patients who are using insulin 2) Patient with recent HbA1c >= 12.1% 3) Patients with weight loss> 5 kg within the past 6 months 4) Patients with recent eGFR <30 ml/min / 1.73 m2 5) Patients with drug addiction 6) Patients with malignant tumors 7) Patients who developed myocardial infarction within the past 6 months 8) Patients with grade 3 or higher severe heart failure of the New York Heart Association (NYHA) 9) Patients with learning disabilities 10) Patients being treated with antiobesity drugs 11) Patients diagnosed with eating disorders 12) Pregnant women, lactating women and patients with the possibility of being pregnant (intention) 13) Patients who need inpatient treatment due to depression or patients with antipsychotic oral administration 14) Patients participating in other clinical studies 15) Patients judged inappropriate for judgment by doctor's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) Weight after 6 months from start (weight loss of 10% or more from the start) (2) HbA1c (less than 6.5% HbA1c without diabetes medicine) after 6 months from start | — |
Countries
Japan
Contacts
Asama General Hospital Diabetes Medicine